دورية أكاديمية

A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer

التفاصيل البيبلوغرافية
العنوان: A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer
المؤلفون: Duska, L.R., Krasner, C.N., O'Malley, D.M., Hays, J.L., Modesitt, S.C., Mathews, C.A., Moore, K.N., Thaker, P.H., Miller, A., Purdy, C., Zamboni, W.C., Lucas, A.T., Supko, J.G., Schilder, R.J.
المصدر: In Gynecologic Oncology March 2021 160(3):688-695
قاعدة البيانات: ScienceDirect
الوصف
تدمد:00908258
DOI:10.1016/j.ygyno.2020.12.025